Cronos Group Inc. (CRON)

Name: Cronos Group Inc. (CRON) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001656472 · Nasdaq · Medicinal Chemicals & Botanical Products

Sector Manufacturing
Fiscal year ends Dec 31

For the year ended 2025-12-31, Cronos Group Inc. reported revenue of $146.59M. Revenue grew 24.6% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $179.09M.

Key ratios (year ended 2025-12-31)

42.8%

Gross margin

-11.9%

Operating margin

-6.4%

Net margin

-0.8%

Return on year-end equity

24.6%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-15

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Revenue	$179.09M	$146.59M	$117.61M	$87.24M	$86.75M	$64.56M	$46.72M	$23.75M	$12.12M	$3.15M
Gross Profit	$82.12M	$62.76M	$25.20M	$11.91M	$15.44M	-$17.59M	-$25.83M	-$17.60M	$6.21M	$1.57M
R&D Expense	$5.36M	$4.45M	$4.23M	$5.84M	$13.13M	$21.84M	$20.37M	$12.15M	$1.81M	$0
Operating Income	-$2.43M	-$17.39M	-$76.53M	-$84.80M	-$111.43M	-$291.97M	-$219.39M	-$153.32M	-$20.45M	-$6.12M
Depreciation & Amortization	$14.29M	$14.23M	$9.34M	$8.11M	$13.12M	$15.40M	$7.04M	$4.27M	$1.94M	$768.0K
EBITDA	$11.86M	-$3.16M	-$67.19M	-$76.69M	-$98.31M	-$276.57M	-$212.34M	-$149.04M	-$18.51M	-$5.35M
Net Income	$69.98M	-$9.45M	$41.08M	-$73.96M	-$168.73M	-$396.11M	-$73.14M	$1.17B	-$21.64M	-$1.48M
EPS (Diluted)	n/a	-$0.02	$0.11	-$0.19	-$0.45	-$1.07	-$0.21	$3.33	-$0.12	-$0.01
Total Assets	$1.18B	$1.20B	$1.17B	$1.14B	$1.21B	$1.40B	$1.93B	$2.09B	$183.47M	n/a
Total Liabilities	$62.41M	$54.18M	$55.33M	$44.14M	$72.05M	$63.46M	$217.51M	$341.41M	$34.92M	n/a
Shareholders' Equity	$1.12B	$1.14B	$1.11B	$1.10B	$1.14B	$1.33B	$1.71B	$1.75B	$148.55M	$63.73M
Cash & Equivalents	$467.02M	$791.79M	$858.80M	$669.29M	$764.64M	$886.97M	$1.08B	$1.20B	$23.93M	n/a
Operating Cash Flow	$60.05M	$25.87M	$18.84M	-$42.84M	-$88.95M	-$153.62M	-$144.87M	-$131.19M	-$7.52M	-$4.28M
Capital Expenditures	$10.24M	$25.72M	$12.41M	$2.50M	$3.45M	$11.14M	$31.41M	$38.66M	$88.31M	$32.93M
Free Cash Flow	$49.82M	$149.0K	$6.43M	-$45.34M	-$92.40M	-$164.76M	-$176.28M	-$169.86M	-$95.83M	-$37.20M
Share Repurchases	$38.99M	$9.74M	$0	$0	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding	370.73M	381.59M	382.53M	381.30M	380.58M	374.95M	360.25M	n/a	n/a	n/a
Weighted Average Diluted Shares	n/a	383.47M	385.56M	380.96M	376.96M	370.39M	351.58M	342.81M	172.27M	176.79M
EPS (Basic)	n/a	-$0.02	$0.11	-$0.19	-$0.45	-$1.07	-$0.21	$3.76	-$0.12	-$0.01

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView